Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morel Rubinger

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 25, 2007
The role of hematopoietic stem cell transplantation in advanced Hodgkin LymphomaMatthew Seftel, Morel Rubinger
American Journal of Hematology|February 9, 2002
Autologous peripheral stem cell transplantation for aggressive hemophagocytic syndrome associated with T-cell lymphoma: case study and reviewDavinder S Jassal, Ken Kasper, Carmen Morales, et al.
Plos One|June 14, 2013
Early stage W.H.O. grade I and II follicular lymphoma treated with radiation therapy aloneNaseer Ahmed, Timothy E Owen, Morel Rubinger, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphomaHong-Wei Liu, Matthew D Seftel, Morel Rubinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimenRichard J Klasa, Ralph M Meyer, Chaim Shustik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2014
Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remissionJennifer L Holter Chakrabarty, Morel Rubinger, Jennifer Le-Rademacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials GroupLaurie H Sehn, David MacDonald, Sheldon Rubin, et al.
Translational Oncology|January 28, 2014
Three-dimensional Nuclear Telomere Organization in Multiple MyelomaLudger Klewes, Rhea Vallente, Eric Dupas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant groupDiego Villa, Michael Crump, Tony Panzarella, et al.
Blood|January 9, 2013
A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 TrialA Keith Stewart, Suzanne Trudel, Nizar J Bahlis, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 25, 2007
The role of hematopoietic stem cell transplantation in advanced Hodgkin LymphomaMatthew Seftel, Morel Rubinger
American Journal of Hematology|February 9, 2002
Autologous peripheral stem cell transplantation for aggressive hemophagocytic syndrome associated with T-cell lymphoma: case study and reviewDavinder S Jassal, Ken Kasper, Carmen Morales, et al.
Plos One|June 14, 2013
Early stage W.H.O. grade I and II follicular lymphoma treated with radiation therapy aloneNaseer Ahmed, Timothy E Owen, Morel Rubinger, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphomaHong-Wei Liu, Matthew D Seftel, Morel Rubinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimenRichard J Klasa, Ralph M Meyer, Chaim Shustik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2014
Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remissionJennifer L Holter Chakrabarty, Morel Rubinger, Jennifer Le-Rademacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials GroupLaurie H Sehn, David MacDonald, Sheldon Rubin, et al.
Translational Oncology|January 28, 2014
Three-dimensional Nuclear Telomere Organization in Multiple MyelomaLudger Klewes, Rhea Vallente, Eric Dupas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant groupDiego Villa, Michael Crump, Tony Panzarella, et al.
Blood|January 9, 2013
A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 TrialA Keith Stewart, Suzanne Trudel, Nizar J Bahlis, et al.
Pageof 2